Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
- PMID: 16336670
- PMCID: PMC1325044
- DOI: 10.1186/1477-9560-3-20
Anticoagulant treatment at a specialized outpatient anticoagulant therapy unit, a descriptive study
Abstract
Background: The indications for continuous oral anticoagulant treatment, the target interval and the procedures for withdrawing treatment have changed in the last 10 years.
Methods: Patients on continuous oral anticoagulant treatment at the Outpatient Anticoagulant Clinic at Umeå University Hospital in 2002 were included in a descriptive study (n = 900). 263 of those had a mechanical heart valve prosthesis. Only patient records for patients with other indications than mechanical heart valve prosthesis were examined. 582 of those records were found. In the 55 remaining patients some clinical information was retrieved from the computerised warfarin dosage database. These latter, more unsure clinical data, are presented separately. Anticoagulant treatment was discontinued if lack of proper indication or presence of too high risk for hemorrhagic complications were found.
Results: The prevalence of continuous oral anticoagulant treatment in the uptake area was 0.65%. The most common target interval was INR 2.1-3.0, but patients with a mechanical heart valve prosthesis were often treated more aggressively, i.e. with a higher INR target interval. Of the patients on continuous treatment, 26.6% of the INR values were outside 2.0-3.0. The most common reasons for oral anticoagulant treatment were atrial fibrillation or mechanical heart valve prosthesis, in contrast to earlier findings in studies of our population in 1987 and 1990. We found 90 patients (10.0%) without proper indication for oral anticoagulant treatment or too high risk, and their treatment was discontinued.
Conclusion: In patients on oral anticoagulant therapy, re-evaluation of indications and risks resulted in a substantial number of treatment withdrawals. There have been major changes in treatment indications during the last decade, possibly due to rapid development of knowledge in the field of thrombosis risk factors. Treatment should be re-considered once a year.
Similar articles
-
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.Arch Intern Med. 2009 Jul 13;169(13):1203-9. doi: 10.1001/archinternmed.2009.176. Arch Intern Med. 2009. PMID: 19597069
-
Mechanical heart valve patients can manage oral anticoagulant therapy themselves.Eur J Cardiothorac Surg. 2003 Mar;23(3):292-8. doi: 10.1016/s1010-7940(02)00817-5. Eur J Cardiothorac Surg. 2003. PMID: 12614796 Review.
-
Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation.Arch Intern Med. 2001 Sep 24;161(17):2125-8. doi: 10.1001/archinte.161.17.2125. Arch Intern Med. 2001. PMID: 11570942
-
Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.Arch Gynecol Obstet. 2016 Jan;293(1):69-74. doi: 10.1007/s00404-015-3768-0. Epub 2015 Jun 6. Arch Gynecol Obstet. 2016. PMID: 26048261
-
Anticoagulation after artificial valve replacement with or without atrial fibrillation: how much is really needed?Thromb Haemost. 1999 Sep;82 Suppl 1:130-5. Thromb Haemost. 1999. PMID: 10695504 Review.
Cited by
-
Anticoagulation Management of Atrial Fibrillation: The Relationship of Prevailing Adherence to a Dose Protocol and Recall Schedule on TTR in Primary Care.Health Serv Res Manag Epidemiol. 2014 Sep 22;1:2333392814552524. doi: 10.1177/2333392814552524. eCollection 2014 Jan-Dec. Health Serv Res Manag Epidemiol. 2014. PMID: 28462246 Free PMC article.
-
A cross-sectional study of the Anticoagulation Clinic in RIPAS Hospital, Brunei.J Thromb Thrombolysis. 2009 Aug;28(2):140-5. doi: 10.1007/s11239-008-0257-3. Epub 2008 Jul 30. J Thromb Thrombolysis. 2009. PMID: 18665329
References
-
- Johnsson H. [Anticoagulant therapy can be safer. An active follow-up and written care programs reduce the number of complications] Lakartidningen. 1999;96:3388–3390. - PubMed
-
- Holm T, Lassen JF. [How many patients are on oral anticoagulant therapy in Denmark? Methods to estimate the number] Ugeskr Laeger. 2003;165:1871–1875. - PubMed
-
- Stigendal L, Johnsson H. Information från Läkemedelsverket. Vol. 9. Medical Products Agency; 1998. Apekumarol ersätts nu med waran, exempel på patientinformation.
-
- Taghavi A, Jonson T, Stockelberg D. [Survey of complications following treatment with anticoagulants. A computerized search for hemorrhagic complications completes manual reporting] Lakartidningen. 1999;96:3421–3424. - PubMed
-
- Jansson JH, Westman G, Boman K, Nilsson T, Norberg B. Oral anticoagulant treatment in a medical care district--a descriptive study. Scand J Prim Health Care. 1995;13:268–274. - PubMed
LinkOut - more resources
Full Text Sources